Total Payments
$17,955
2024 Payments
$2,692
Companies
42
Transactions
909
Medicare Patients
9,242
Medicare Billing
$718,791
Payment Breakdown by Category
Food & Beverage$17,817 (99.2%)
Education$137.94 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,817 | 904 | 99.2% |
| Education | $137.94 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,277 | 160 | $0 (2024) |
| ABBVIE INC. | $2,136 | 99 | $0 (2024) |
| UCB, Inc. | $2,003 | 82 | $0 (2024) |
| Amgen Inc. | $1,262 | 58 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,102 | 58 | $0 (2024) |
| Celgene Corporation | $800.93 | 47 | $0 (2019) |
| Janssen Biotech, Inc. | $788.18 | 47 | $0 (2024) |
| Genentech USA, Inc. | $758.33 | 39 | $0 (2024) |
| Lilly USA, LLC | $752.15 | 34 | $0 (2024) |
| LEO Pharma Inc. | $673.71 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,692 | 123 | ABBVIE INC. ($419.90) |
| 2023 | $2,728 | 131 | UCB, Inc. ($346.41) |
| 2022 | $2,012 | 105 | Lilly USA, LLC ($269.24) |
| 2021 | $1,925 | 103 | Novartis Pharmaceuticals Corporation ($342.90) |
| 2020 | $1,685 | 76 | Amgen Inc. ($507.37) |
| 2019 | $2,828 | 129 | AbbVie, Inc. ($520.82) |
| 2018 | $1,874 | 115 | Novartis Pharmaceuticals Corporation ($322.14) |
| 2017 | $2,210 | 127 | Novartis Pharmaceuticals Corporation ($335.37) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 4 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: Immunology | ||||||
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: Immunology | ||||||
| 05/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: DERMATOLOGY | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.22 | General |
| Category: Dermatology | ||||||
| 04/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Dermatology | ||||||
| 03/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.93 | General |
| Category: Immunology | ||||||
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $121.29 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 03/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: Immunology | ||||||
| 03/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.83 | General |
| Category: Immunology | ||||||
| 03/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Immunology | ||||||
| 03/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.47 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Immunology | ||||||
| 03/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Dermatology | ||||||
| 03/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Immunology | ||||||
| 03/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Dermatology | ||||||
| 02/29/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,317 | 5,205 | $1.0M | $190,285 |
| 2022 | 17 | 2,161 | 4,696 | $446,854 | $174,615 |
| 2021 | 20 | 2,246 | 4,155 | $465,311 | $180,806 |
| 2020 | 24 | 2,518 | 4,835 | $496,794 | $173,085 |
Total Patients
9,242
Total Services
18,891
Medicare Billing
$718,791
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 639 | 901 | $286,518 | $53,400 | 18.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 329 | 421 | $259,757 | $50,223 | 19.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 385 | 488 | $119,560 | $20,069 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 336 | 2,605 | $65,125 | $12,228 | 18.8% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 60 | 65 | $37,245 | $7,823 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $41,658 | $7,705 | 18.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 34 | 37 | $27,528 | $5,746 | 20.9% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 58 | $29,754 | $5,356 | 18.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 90 | 110 | $22,110 | $4,319 | 19.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 33 | $21,483 | $3,731 | 17.4% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 39 | 43 | $21,844 | $3,627 | 16.6% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 29 | 31 | $16,089 | $3,047 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 30 | $13,380 | $2,643 | 19.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $10,290 | $1,994 | 19.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 22 | 24 | $10,896 | $1,688 | 15.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 19 | 19 | $8,968 | $1,618 | 18.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $7,824 | $1,346 | 17.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 17 | $7,140 | $1,339 | 18.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 19 | 21 | $7,980 | $1,226 | 15.4% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 13 | 13 | $2,847 | $611.78 | 21.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 40 | $2,040 | $446.00 | 21.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 116 | $464.00 | $98.58 | 21.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 371 | 457 | $155,837 | $54,178 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 642 | 864 | $101,088 | $51,679 | 51.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 345 | 390 | $52,650 | $17,427 | 33.1% |
About Dr. Robert Albergo, MD
Dr. Robert Albergo, MD is a Dermatology healthcare provider based in Palm Harbor, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063496438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Albergo, MD has received a total of $17,955 in payments from pharmaceutical and medical device companies, with $2,692 received in 2024. These payments were reported across 909 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($17,817).
As a Medicare-enrolled provider, Albergo has provided services to 9,242 Medicare beneficiaries, totaling 18,891 services with total Medicare billing of $718,791. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Palm Harbor, FL
- Active Since 11/30/2005
- Last Updated 02/27/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1063496438
Products in Payments
- Otezla (Drug) $1,750
- COSENTYX (Biological) $1,634
- Cimzia (Drug) $1,526
- SKYRIZI (Biological) $792.92
- Erivedge (Biological) $738.50
- TALTZ (Drug) $724.60
- Humira (Biological) $716.24
- DUPIXENT (Biological) $657.68
- COSENTYX (Drug) $543.45
- ENSTILAR (Drug) $475.88
- ILUMYA (Biological) $447.45
- OPZELURA (Drug) $411.90
- Odomzo (Drug) $402.46
- Bimzelx (Biological) $378.86
- Sotyktu (Drug) $373.96
- TREMFYA (Drug) $373.31
- VTAMA (Drug) $327.17
- RINVOQ (Biological) $316.45
- Enbrel (Biological) $312.91
- DORYX (Drug) $272.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.